ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,779Medicare Part D Prescriptions Filled, Including Refills

Rank: 42 out of 273

$529K Total Retail Price of All Prescriptions

Rank: 57 out of 273

849 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 8,049 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
CARVEDILOL 1,398 1,096 1 3
CRESTOR 622 456 2 14
AMLODIPINE BESYLATE 609 521 3 2
SIMVASTATIN 564 466 4 6
PRAVASTATIN SODIUM 491 346 5 11
METOPROLOL SUCCINATE 486 331 6 1
ISOSORBIDE MONONITRATE ER 439 320 7 13
PLAVIX 420 303 8 12
WARFARIN SODIUM 316 218 9 7
CILOSTAZOL 253 205 10 56
CLOPIDOGREL 250 188 11 9
TRIAMTERENE-HCTZ 225 174 12 53
LOSARTAN POTASSIUM 218 182 13 19
HYDRALAZINE HCL 215 189 14 36
HYDROCHLOROTHIAZIDE 179 146 15 16
FUROSEMIDE 178 128 16 5
BENAZEPRIL HCL 177 121 17 35
NITROSTAT 176 101 18 28
LISINOPRIL 155 110 19 4
FENOFIBRATE 148 87 20 34
LOSARTAN-HYDROCHLOROTHIAZIDE 142 123 21 40
VERAPAMIL ER 133 90 22 64
AZOR 128 88 23 116
AMIODARONE HCL 124 105 24 23
SPIRONOLACTONE 120 85 25 20
RAMIPRIL 111 69 26 24
OMEPRAZOLE 110 85 27 33
AMLODIPINE BESYLATE-BENAZEPRIL 109 76 28 47
BENAZEPRIL-HYDROCHLOROTHIAZIDE 102 77 29 111
BENICAR 101 73 30 88
RANITIDINE HCL 101 79 30 78
EFFIENT 95 60 32 67
PANTOPRAZOLE SODIUM 91 66 33 41
ATORVASTATIN CALCIUM 90 77 34 8
ZETIA 88 64 35 30
DIOVAN 65 52 36 21
DIGOXIN 63 48 37 15
VYTORIN 62 52 38 68
MICARDIS 61 53 39 140
CLONIDINE HCL 60 46 40 32
BENICAR HCT 60 36 40 105
LEVOTHYROXINE SODIUM 57 57 42 25
TRILIPIX 56 17 43 75
TRANDOLAPRIL 55 46 44 109
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 31 45 38
PENTOXIFYLLINE 53 50 46 250
NEXIUM 53 33 46 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 13, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.